Dillon & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.65M Sell
23,173
-435
-2% -$101K 0.78% 32
2025
Q4
$4.89M Sell
23,608
-399
-2% -$78.9K 0.63% 34
2025
Q3
$4.44M Sell
24,007
-86
-0.4% -$14.7K 0.57% 37
2025
Q2
$3.69M Sell
24,093
-76
-0.3% -$11.7K 0.5% 37
2025
Q1
$4.01M Sell
24,169
-257
-1% -$40.2K 0.6% 35
2024
Q4
$3.54M Sell
24,426
-121
-0.5% -$18.8K 0.49% 37
2024
Q3
$3.98M Sell
24,547
-213
-0.9% -$33.9K 0.56% 35
2024
Q2
$3.62M Sell
24,760
-278
-1% -$41.3K 0.53% 37
2024
Q1
$3.96M Sell
25,038
-701
-3% -$112K 0.62% 35
2023
Q4
$4.04M Sell
25,739
-1,864
-7% -$286K 0.73% 36
2023
Q3
$4.31M Sell
27,603
-350
-1% -$57.8K 0.83% 33
2023
Q2
$4.64M Sell
27,953
-845
-3% -$136K 0.85% 31
2023
Q1
$4.46M Sell
28,798
-1,906
-6% -$308K 0.89% 29
2022
Q4
$5.43M Sell
30,704
-837
-3% -$145K 1.18% 27
2022
Q3
$5.14M Buy
31,541
+100
+0.3% +$16.9K 1.19% 27
2022
Q2
$5.6M Sell
31,441
-500
-2% -$89.1K 1.26% 29
2022
Q1
$5.65M Sell
31,941
-522
-2% -$88.8K 1.07% 30
2021
Q4
$5.55M Buy
32,463
+84
+0.3% +$13.8K 0.97% 30
2021
Q3
$5.25M Sell
32,379
-555
-2% -$94.7K 1% 29
2021
Q2
$5.43M Sell
32,934
-1,350
-4% -$223K 1.06% 28
2021
Q1
$5.62M Sell
34,284
-1,730
-5% -$280K 1.2% 29
2020
Q4
$5.65M Sell
36,014
-460
-1% -$67.9K 1.23% 27
2020
Q3
$5.43M Sell
36,474
-459
-1% -$67.9K 1.31% 27
2020
Q2
$5.21M Sell
36,933
-85
-0.2% -$12.4K 1.41% 27
2020
Q1
$4.85M Sell
37,018
-8,400
-18% -$1.19M 1.63% 26
2019
Q4
$6.63M Sell
45,418
-7,255
-14% -$984K 1.86% 24
2019
Q3
$6.79M Sell
52,673
-2,969
-5% -$391K 2.07% 24
2019
Q2
$7.73M Sell
55,642
-250
-0.4% -$34.6K 2.39% 19
2019
Q1
$7.83M Sell
55,892
-395
-0.7% -$52.9K 2.54% 15
2018
Q4
$7.26M Sell
56,287
-1,573
-3% -$219K 2.77% 12
2018
Q3
$7.99M Sell
57,860
-729
-1% -$96.9K 2.64% 13
2018
Q2
$7.09M Sell
58,589
-730
-1% -$91.1K 2.62% 13
2018
Q1
$7.59M Sell
59,319
-749
-1% -$101K 2.93% 11
2017
Q4
$8.41M Sell
60,068
-1,370
-2% -$191K 3.17% 11
2017
Q3
$7.99M Sell
61,438
-525
-0.8% -$69.6K 3.15% 11
2017
Q2
$8.18M Sell
61,963
-1,264
-2% -$161K 3.37% 11
2017
Q1
$7.9M Sell
63,227
-1,175
-2% -$140K 3.36% 10
2016
Q4
$7.41M Sell
64,402
-455
-0.7% -$52.6K 3.37% 10
2016
Q3
$7.65M Sell
64,857
-461
-0.7% -$55.9K 3.53% 10
2016
Q2
$7.9M Sell
65,318
-1,075
-2% -$122K 3.63% 9
2016
Q1
$7.17M Sell
66,393
-25
-0% -$2.59K 3.33% 10
2015
Q4
$6.84M Sell
66,418
-1,527
-2% -$154K 3.31% 11
2015
Q3
$6.32M Sell
67,945
-100
-0.1% -$9.67K 3.16% 12
2015
Q2
$6.6M Sell
68,045
-720
-1% -$72.1K 3.22% 12
2015
Q1
$6.95M Sell
68,765
-275
-0.4% -$28K 3.33% 13
2014
Q4
$7.25M Sell
69,040
-250
-0.4% -$26.3K 3.52% 11
2014
Q3
$7.41M Sell
69,290
-825
-1% -$85.6K 3.78% 7
2014
Q2
$7.36M Sell
70,115
-456
-0.6% -$46.1K 3.77% 7
2014
Q1
$6.92M Sell
70,571
-1,540
-2% -$143K 3.7% 7
2013
Q4
$6.63M Sell
72,111
-1,303
-2% -$120K 3.58% 9
2013
Q3
$6.83M Sell
73,414
-700
-0.9% -$62.8K 3.82% 8
2013
Q2
$6.37M Buy
+74,114
New +$6.29M 4.08% 8

Other funds holding JNJ

Dillon & Associates's JNJ Position: Q1 2026 in Review

Dillon & Associates reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $101K and leaving 23,173 shares worth $5.65M. The position accounts for 0.78% of the portfolio, ranked #32.

Dillon & Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.41M in Q4 2017. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Dillon & Associates held 23,173 shares of Johnson & Johnson worth $5.65M as of Q1 2026.
  • Dillon & Associates sold 435 Johnson & Johnson shares in Q1 2026, an estimated $101K.
  • Johnson & Johnson made up 0.78% of Dillon & Associates's portfolio in Q1 2026, its #32 holding.
  • Dillon & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Dillon & Associates's Johnson & Johnson position peaked at $8.41M in Q4 2017.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Dillon & Associates's 13F filing for Q1 2026, filed 7 May 2026.